DOse and administration Time of Indocyanine Green in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy (DOTIG): a randomized clinical trial
Surgical Endoscopy · 2025-03 · 39 (3) · 1778-1792
DOI: 10.1007/s00464-024-11481-8 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Surgical Endoscopy, online erschienen am 16.01.2025. Verfasst von Jaime López-Sánchez und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Gastrointestinal Surgery, Complejo Asistencial Universitario de Salamanca, Paseo de la Transición Española, 37007, Salamanc…. Hauptthemen laut MEDLINE: Indocyanine Green, Cholecystectomy, Laparoscopic, Cholangiography, Intraoperative Complications. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León (IESCYL)-Instituto de Investigación Biomédica de Salamanca.
Abstract (Originalsprache)
BACKGROUND: Different techniques have been proposed to reduce the incidence of the intraoperative bile duct injury during laparoscopic cholecystectomy (LC). Among these, Near-Infrared Fluorescence Cholangiography (NIFC) with Indocyanine Green (ICG) represents a relatively recent addition. At present, there is considerable variation in the protocols for the administration of ICG. METHODS: The aim of this randomized multicenter clinical trial (RCT) is to ascertain whether there are differences between the dosage and administration intervals of ICG, with a view to optimizing a good-quality NIFC during LC. Furthermore, an analysis was conducted to determine the potential impact of different factors on the outcomes of this technique. The trial was approved by the local institutional Ethics Committee. RESULTS: From June 2022 to June 2023, 200 patients were randomized in four arms (G1: 2.5 mg ICG > 3 h prior to surgery, G2: 2.5 mg ICG 15-30 min prior to surgery, G3: 0.05 mg/kg ICG > 3 h prior to surgery and G4: 0.05 mg/kg ICG 15-30 min prior to surgery). We found differences in the DISTURBED score between the groups (p 3 h after LC (p = 0.02). Additionally, it was observed that body mass index (BMI), gender, ASA Classification System, previous liver and biliary disease and the type of surgery had influence on NIFC. Finally, the NIFC had an impact in intraoperative and postoperative complications, operative time and hospital length of stay. CONCLUSIONS: The administration of ICG > 3 h improve liver background fluorescence in the NIFC during LC. There are different factors may affect NIFC results (BMI, ASA grade, previous liver disease, presence of gallbladder inflammation and type of surgery). Finally, high-quality NIFC was associated with fewer surgical complications, shorter surgical time and shorter length of hospital stay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General and Gastrointestinal Surgery, Complejo Asistencial Universitario de Salamanca, Paseo de la Transición Española, 37007, Salamanca, Spain. jalopsan@hotmail.com.
- Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain. jalopsan@hotmail.com.
- Department of General and Gastrointestinal Surgery, Complejo Asistencial Universitario de Salamanca, Paseo de la Transición Española, 37007, Salamanca, Spain.
- Department of General and Gastrointestinal Surgery, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
- UICEC-Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain.
- Clinical Trials Unit. Pharmacology Department, Hospital Universitario de Canarias, La Laguna, Spain.
ORCID-Profile: Jaime López-Sánchez
Förderung
- Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León (IESCYL)-Instituto de Investigación Biomédica de Salamanca
Zitieren
APA
López-Sánchez, J., Garrosa-Muñoz, S., Pardo-Aranda, F., Zarate, A., López-Pérez, R., Rodríguez-Fortúnez, P., Sánchez-Santos, J. M., Esteban, C., Quiñones, J., Iglesias, M., González, L., Trébol, J., Sánchez-Casado, A., García-Plaza, A., González-Muñoz, J. I., Abdel-Lah, O., Genè, C., Cremades, M., Espín, F., …, & Blanco-Antona, F. (2025). DOse and administration Time of Indocyanine Green in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy (DOTIG): a randomized clinical trial. Surgical Endoscopy, 39(3), 1778-1792. https://doi.org/10.1007/s00464-024-11481-8
Vancouver
López-Sánchez J, Garrosa-Muñoz S, Pardo-Aranda F, Zarate A, López-Pérez R, Rodríguez-Fortúnez P, et al. DOse and administration Time of Indocyanine Green in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy (DOTIG): a randomized clinical trial. Surgical Endoscopy. 2025;39(3):1778-1792. doi:10.1007/s00464-024-11481-8
BibTeX
@article{LpezSnchez2025,
author = {López-Sánchez, Jaime and Garrosa-Muñoz, Sonsoles and Pardo-Aranda, Fernando and Zarate, Alba and López-Pérez, Ricardo and Rodríguez-Fortúnez, Patricia and Sánchez-Santos, José Manuel and Esteban, Carmen and Quiñones, José and Iglesias, Manuel and González, Luis and Trébol, Jacobo and Sánchez-Casado, Ana and García-Plaza, Asunción and González-Muñoz, Juan Ignacio and Abdel-Lah, Omar and Genè, Clara and Cremades, Manel and Espín, Francisco and Navinés, Jordi and Vidal, Laura and Piqueras, Ana and Senti, Sara and Herrero, Christian and Cugat, Esteban and Muñoz-Bellvís, Luis and Blanco-Antona, Francisco},
title = {DOse and administration Time of Indocyanine Green in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy (DOTIG): a randomized clinical trial},
journal = {Surgical Endoscopy},
year = {2025},
volume = {39},
number = {3},
pages = {1778--1792},
doi = {10.1007/s00464-024-11481-8}
}
EUVIMED